OrganiGram Holdings Inc (OGI)

NASDAQ
Currency in USD
1.0700
+0.0300(+2.88%)
Closed·
Pre Market
1.1100+0.0400(+3.74%)
·
OGI Scorecard
Full Analysis
Holds more cash than debt on its balance sheet
Fair Value
Day's Range
1.03001.0900
52 wk Range
0.85002.1700
Key Statistics
Edit
Prev. Close
1.07
Open
1.04
Day's Range
1.03-1.09
52 wk Range
0.85-2.17
Volume
418.97K
Average Volume (3m)
868.59K
1-Year Change
-43.39%
Book Value / Share
1.78
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
OGI Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Analysts Sentiment
Currently not supported.
Members' Sentiments
Bearish
Bullish
ProTips
Analysts do not anticipate the company will be profitable this year
Show more

OrganiGram Holdings Inc Company Profile

Organigram Global Inc. engages in the production and sale of cannabis and cannabis-derived products in Canada. It offers medical cannabis products, including whole flower, milled flower, pre-rolls, infused pre-rolls, vapes, beverages, gummies, and concentrates; and adult use recreational cannabis under the SHRED, Holy Mountain, Big Bag O’ Buds, Monjour, Trailblazer, SHRED'ems, Edison Cannabis Co., Boxhot, Edison JOLTS, Wola, Rizzlers, DEBUNK, Tremblant, and Laurentian brands. The company also engages in the wholesale shipping of cannabis plant cuttings and dried flowers to other licensed producers. It sells cannabis products to wholesale and retail channels in the recreational and medical cannabis regimes, as well as through online. Organigram Global Inc. was formerly known as Organigram Holdings Inc. and changed its name to Organigram Global Inc. in March 2025. The company was incorporated in 2010 and is headquartered in Toronto, Canada.

OrganiGram Holdings Inc Earnings Call Summary for Q1/2025

  • Net revenue up 25% YoY, positive adjusted EBITDA of $3.5M, net income of $2.8M in Q3 2024
  • Stock fell 10.98% in premarket trading despite strong results; company appears undervalued per InvestingPro analysis
  • Launched new cannabis technology with faster effect onset; maintained strong market position in Canada
  • Targeting 36% gross margin, focusing on international expansion, particularly in Germany with EU GMP certification expected in early 2025
  • CEO confident in growth trajectory, highlighting German market as "next big phase wave of growth" for OrganiGram
Last Updated: 12/02/2025, 12:48 am
Read Full Transcript

Compare OGI to Peers and Sector

Metrics to compare
OGI
Peers
Sector
Relationship
P/E Ratio
−3.8x−0.5x−0.5x
PEG Ratio
-−0.010.00
Price/Book
0.6x0.5x2.6x
Price / LTM Sales
1.2x0.9x2.9x
Upside (Analyst Target)
204.7%146.2%66.0%
Fair Value Upside
Unlock18.5%10.6%Unlock

Earnings

Latest Release
Nov 27, 2023
EPS / Forecast
-0.37 / -0.0231
Revenue / Forecast
46.04M / 34.21M
EPS Revisions
Last 90 days

People Also Watch

65.69
BNS
+0.55%
6.00
CS
+0.33%
39.88
CNQ
+2.07%
16.75
CVE
+3.65%
129.32
BMO
+0.47%

FAQ

What Is the OrganiGram Holdings Inc (OGI) Stock Price Today?

The OrganiGram Holdings Inc stock price today is 1.07

What Stock Exchange Does OrganiGram Holdings Inc Trade On?

OrganiGram Holdings Inc is listed and trades on the NASDAQ stock exchange.

What Is the Stock Symbol for OrganiGram Holdings Inc?

The stock symbol for OrganiGram Holdings Inc is "OGI."

What Is the OrganiGram Holdings Inc Market Cap?

As of today, OrganiGram Holdings Inc market cap is 142.97M.

What is OrganiGram Holdings Inc Earnings Per Share?

The OrganiGram Holdings Inc EPS is -0.51.

From a Technical Analysis Perspective, Is OGI a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Buy.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2025 - Fusion Media Limited. All Rights Reserved.